|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
60,492,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,682,564 |
Avg
Vol: |
2,636,078 |
52
Week Range: |
$31.96 - $31.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Denby William C |
Sr. VP, Commercial Operations |
|
2014-01-02 |
4 |
A |
$3.33 |
$871,124 |
D/D |
145,015 |
202,182 |
|
- |
|
Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
|
2014-01-02 |
4 |
D |
$32.00 |
$3,698,816 |
D/D |
(115,588) |
0 |
|
- |
|
Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
|
2014-01-02 |
4 |
A |
$2.30 |
$500,133 |
D/D |
115,588 |
115,588 |
|
- |
|
Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
|
2014-01-02 |
4 |
D |
$32.00 |
$4,330,816 |
D/D |
(135,338) |
0 |
|
- |
|
Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
|
2014-01-02 |
4 |
D |
$32.00 |
$7,042,560 |
D/D |
(220,080) |
135,338 |
|
- |
|
Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
|
2014-01-02 |
4 |
D |
$32.00 |
$996,800 |
D/D |
(31,150) |
355,418 |
|
- |
|
Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
|
2014-01-02 |
4 |
A |
$1.18 |
$996,813 |
D/D |
220,080 |
386,568 |
|
- |
|
Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
|
2014-01-02 |
4 |
D |
$32.00 |
$1,100,864 |
D/D |
(34,402) |
0 |
|
- |
|
Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
|
2014-01-02 |
4 |
D |
$32.00 |
$2,980,320 |
D/D |
(93,135) |
34,402 |
|
- |
|
Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
|
2014-01-02 |
4 |
D |
$32.00 |
$458,720 |
D/D |
(14,335) |
127,537 |
|
- |
|
Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
|
2014-01-02 |
4 |
A |
$3.33 |
$458,729 |
D/D |
93,135 |
141,872 |
|
- |
|
Fox Carey J |
Sr VP, General Counsel |
|
2014-01-02 |
4 |
D |
$32.00 |
$6,432 |
D/D |
(201) |
0 |
|
- |
|
Fox Carey J |
Sr VP, General Counsel |
|
2014-01-02 |
4 |
D |
$32.00 |
$5,497,792 |
D/D |
(171,806) |
201 |
|
- |
|
Fox Carey J |
Sr VP, General Counsel |
|
2014-01-02 |
4 |
D |
$32.00 |
$786,144 |
D/D |
(24,567) |
172,007 |
|
- |
|
Fox Carey J |
Sr VP, General Counsel |
|
2014-01-02 |
4 |
A |
$2.30 |
$985,336 |
D/D |
171,806 |
196,574 |
|
- |
|
Snyder Kent |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$32,000 |
I/I |
(1,000) |
0 |
|
- |
|
Della Cha Alessandro |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$1,590,880 |
D/D |
(49,715) |
0 |
|
- |
|
Hale David F |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$576,000 |
D/D |
(18,000) |
0 |
|
- |
|
Hale David F |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$9,614,464 |
I/I |
(300,452) |
0 |
|
- |
|
Herman Michael E |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$3,920,384 |
I/I |
(122,512) |
0 |
|
- |
|
Love Ted W |
Director |
|
2014-01-02 |
4 |
D |
$32.00 |
$10,736,000 |
D/D |
(335,500) |
0 |
|
- |
|
Snyder Kent |
Director |
|
2013-12-16 |
4 |
AS |
$31.95 |
$239,599 |
D/D |
(7,500) |
0 |
|
- |
|
Snyder Kent |
Director |
|
2013-12-16 |
4 |
OE |
$1.18 |
$13,470 |
D/D |
7,500 |
7,500 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2013-12-16 |
4 |
AS |
$31.95 |
$1,809,461 |
I/I |
(56,643) |
329,282 |
|
- |
|
Proehl Gerald T |
President & CEO |
|
2013-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
56,643 |
385,925 |
|
- |
|
417 Records found
|
|
Page 2 of 17 |
|
|